Net profit of Aspira Pathlab & Diagnostics reported to Rs 0.99 crore in the quarter ended September 2024 as against net loss of Rs 0.71 crore during the previous quarter ended September 2023. Sales rose 86.14% to Rs 6.18 crore in the quarter ended September 2024 as against Rs 3.32 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales6.183.32 86 OPM %21.84-10.84 - PBDT1.35-0.32 LP PBT0.99-0.71 LP NP0.99-0.71 LP Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live News

Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss of Rs 0.72 crore during the previous quarter ended June 2023. Sales rose 78.46% to Rs 4.64 crore in the quarter ended June 2024 as against Rs 2.60 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.642.60 78 OPM %7.54-12.69 - PBDT0.36-0.33 LP PBT-0.02-0.72 97 NP-0.02-0.72 97 Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live News